Carey John P, Minor Lloyd B, Peng Grace C Y, Della Santina Charles C, Cremer Phillip D, Haslwanter Thomas
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, MD 21287, USA.
J Assoc Res Otolaryngol. 2002 Dec;3(4):430-43. doi: 10.1007/s101620010053. Epub 2002 Mar 26.
The 3-dimensional angular vestibulo-ocular reflexes (AVOR) elicited by rapid rotary head thrusts were studied in 17 subjects with unilateral Ménière's disease before and 2-10 weeks after treatment with intratympanic gentamicin and in 13 subjects after surgical unilateral vestibular destruction (SUVD). Each head thrust was in the horizontal plane or in either diagonal plane of the vertical semicircular canals, so that each head thrust effectively stimulated only one pair of canals. The AVOR gains (eye velocity/head velocity during the 30 ms before peak head velocity) for the head thrusts exciting each individual canal were averaged and taken as a measure of the function of that canal. Prior to intratympanic gentamicin, gains for head thrusts that excited canals on the affected side were 0.91 +/- 0.20 (horizontal canal, HC), 0.78 +/- 0.20 (anterior canal, AC), and 0.83 +/- 0.10 (posterior canal, PC). The asymmetries between these gain values and those for head thrusts that excited the contralateral canals were <2%. In contrast, caloric asymmetries averaged 40% +/- 32%. Intratympanic gentamicin resulted in decreased gains attributable to each canal on the treated side: 0.40 +/- 0.12 (HC), 0.35 +/- 0.14 (AC), 0.31 +/- 0.14 (PC) (p <0.01). However, the gains attributable to contralateral canals dropped only slightly, resulting in marked asymmetries between gains for excitation of ipsilateral canals versus their contralateral mates: HC: 34% +/- 12%, AC: 24% +/- 25%, and PC: 42% +/- 13%. There was no difference in the AVOR gain for excitation of the ipsilateral HC after gentamicin in patients who received a single intratympanic injection (0.39 +/- 0.11, n = 12) in comparison to those who received 2-3 injections (0.42 +/- 0.15, n = 5, p = 0.7). Gain decreases attributed to the gentamicin-treated HC and AC were not as severe as those observed after SUVD. This finding suggests that intratympanic gentamicin causes a partial vestibular lesion that may involve preservation of spontaneous discharge and/or rotational sensitivity of afferents.
在17名单侧梅尼埃病患者中,研究了经鼓室内注射庆大霉素治疗前及治疗后2 - 10周,快速旋转头部推力诱发的三维角前庭眼反射(AVOR),并与13名接受单侧前庭神经切断术(SUVD)的患者进行对比。每次头部推力均在水平面或垂直半规管的任一斜面上,因此每次头部推力仅有效刺激一对半规管。对刺激每个半规管的头部推力的AVOR增益(头部速度峰值前30毫秒内的眼速度/头部速度)进行平均,并以此作为该半规管功能的指标。在鼓室内注射庆大霉素之前,刺激患侧半规管的头部推力增益分别为:水平半规管(HC)0.91±0.20、前半规管(AC)0.78±0.20、后半规管(PC)0.83±0.10。这些增益值与刺激对侧半规管的头部推力增益之间的不对称性<2%。相比之下,冷热试验不对称性平均为40%±32%。鼓室内注射庆大霉素导致治疗侧每个半规管的增益降低:HC为0.40±0.12、AC为0.35±0.14、PC为0.31±0.14(p<0.01)。然而,对侧半规管的增益仅略有下降,导致刺激同侧半规管与对侧半规管的增益之间出现明显不对称:HC为34%±12%;AC为24%±25%;PC为42%±13%。单次鼓室内注射庆大霉素的患者(0.39±0.11,n = 12)与接受2 - 3次注射的患者(0.42±0.15,n = 5,p = 0.7)相比,庆大霉素治疗后刺激同侧HC的AVOR增益无差异。庆大霉素治疗的HC和AC的增益降低程度不如SUVD后观察到的严重。这一发现表明,鼓室内注射庆大霉素会导致部分前庭损伤,可能涉及传入神经自发放电和/或旋转敏感性的保留。